Advancing global herbal medicine: Enhancing herb quality through innovative strategies explored in Hong Kong - An international hub

The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to have problems such as over-limit aflatoxins and toxic alkaloids, and the distributors had to recall the problematic herbs. Despite the negat...

Full description

Saved in:
Bibliographic Details
Published inPhytomedicine Plus : International journal of phytotherapy and phytopharmacology Vol. 5; no. 1; p. 100727
Main Authors Ngai, Hiu-Lam, Shaw, Pang-Chui
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.02.2025
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to have problems such as over-limit aflatoxins and toxic alkaloids, and the distributors had to recall the problematic herbs. Despite the negative business consequences, the problems persisted. This study identified the contributors to such a phenomenon, particularly the reasons for unchanging supply chain practices in Hong Kong. We interviewed 16 stakeholders from the Chinese herbal medicine industry to investigate the reasons behind sub-optimal supply chain practices. The interviews were analysed using a coding framework developed by Pisani and colleagues in 2019 to analyse national risks for medicines of sub-optimal quality. The survey's purpose was to identify risks in market dynamics and policies associated with sub-standard and adulterated medicinal herbs in Hong Kong. Problems with herbs’ quality in Hong Kong are attributed to harvesting, collecting, processing and packaging errors as well as storage errors. Furthermore, batch differences contributed to quality issues. The results revealed the lack of expertise and motivation in the Chinese medicine industry in terms of self-surveillance and the eradication of such errors. Moreover, it was found that chemical inspection tests were generally avoided due to cost and time concerns. The current situation is not conducive to consumer rights and public health protection, and supply chain practices should be improved to provide high-quality herbs to the community consistently. We propose establishing a centralised system to purchase herbs. A track-and-trace electronic system can be set up for efficient tracing of the sources and time of transactions such as herb purchase and dispensing. A registration system of Chinese pharmacists is recommended to ensure professionalism and regulatory responsibility, protect the quality of prescriptions, ensure the safe use of herbs and protect public health. These strategies can facilitate the internationalisation of Hong Kong herbs by achieving high standards of quality. Since Hong Kong is an international city, the implementation of the strategies in this proposal can serve as a demonstration of ways to improve the quality of herbs on a global scale.
AbstractList Background: The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to have problems such as over-limit aflatoxins and toxic alkaloids, and the distributors had to recall the problematic herbs. Despite the negative business consequences, the problems persisted. Purpose: This study identified the contributors to such a phenomenon, particularly the reasons for unchanging supply chain practices in Hong Kong. Study Design: We interviewed 16 stakeholders from the Chinese herbal medicine industry to investigate the reasons behind sub-optimal supply chain practices. The interviews were analysed using a coding framework developed by Pisani and colleagues in 2019 to analyse national risks for medicines of sub-optimal quality. The survey's purpose was to identify risks in market dynamics and policies associated with sub-standard and adulterated medicinal herbs in Hong Kong. Results: Problems with herbs’ quality in Hong Kong are attributed to harvesting, collecting, processing and packaging errors as well as storage errors. Furthermore, batch differences contributed to quality issues. The results revealed the lack of expertise and motivation in the Chinese medicine industry in terms of self-surveillance and the eradication of such errors. Moreover, it was found that chemical inspection tests were generally avoided due to cost and time concerns. Conclusion: The current situation is not conducive to consumer rights and public health protection, and supply chain practices should be improved to provide high-quality herbs to the community consistently. We propose establishing a centralised system to purchase herbs. A track-and-trace electronic system can be set up for efficient tracing of the sources and time of transactions such as herb purchase and dispensing. A registration system of Chinese pharmacists is recommended to ensure professionalism and regulatory responsibility, protect the quality of prescriptions, ensure the safe use of herbs and protect public health. These strategies can facilitate the internationalisation of Hong Kong herbs by achieving high standards of quality. Since Hong Kong is an international city, the implementation of the strategies in this proposal can serve as a demonstration of ways to improve the quality of herbs on a global scale.
The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to have problems such as over-limit aflatoxins and toxic alkaloids, and the distributors had to recall the problematic herbs. Despite the negative business consequences, the problems persisted. This study identified the contributors to such a phenomenon, particularly the reasons for unchanging supply chain practices in Hong Kong. We interviewed 16 stakeholders from the Chinese herbal medicine industry to investigate the reasons behind sub-optimal supply chain practices. The interviews were analysed using a coding framework developed by Pisani and colleagues in 2019 to analyse national risks for medicines of sub-optimal quality. The survey's purpose was to identify risks in market dynamics and policies associated with sub-standard and adulterated medicinal herbs in Hong Kong. Problems with herbs’ quality in Hong Kong are attributed to harvesting, collecting, processing and packaging errors as well as storage errors. Furthermore, batch differences contributed to quality issues. The results revealed the lack of expertise and motivation in the Chinese medicine industry in terms of self-surveillance and the eradication of such errors. Moreover, it was found that chemical inspection tests were generally avoided due to cost and time concerns. The current situation is not conducive to consumer rights and public health protection, and supply chain practices should be improved to provide high-quality herbs to the community consistently. We propose establishing a centralised system to purchase herbs. A track-and-trace electronic system can be set up for efficient tracing of the sources and time of transactions such as herb purchase and dispensing. A registration system of Chinese pharmacists is recommended to ensure professionalism and regulatory responsibility, protect the quality of prescriptions, ensure the safe use of herbs and protect public health. These strategies can facilitate the internationalisation of Hong Kong herbs by achieving high standards of quality. Since Hong Kong is an international city, the implementation of the strategies in this proposal can serve as a demonstration of ways to improve the quality of herbs on a global scale.
ArticleNumber 100727
Author Shaw, Pang-Chui
Ngai, Hiu-Lam
Author_xml – sequence: 1
  givenname: Hiu-Lam
  surname: Ngai
  fullname: Ngai, Hiu-Lam
  organization: School of Life Sciences, The Chinese University of Hong Kong, Shatin N.T., Hong Kong, PR China
– sequence: 2
  givenname: Pang-Chui
  surname: Shaw
  fullname: Shaw, Pang-Chui
  email: pcshaw@cuhk.edu.hk
  organization: School of Life Sciences, The Chinese University of Hong Kong, Shatin N.T., Hong Kong, PR China
BookMark eNqFUU1r3DAQFSGFpGn-QQ_6A97KkmzZpRSWkDahgVzSs9DHyNZWkbayd-me-8crZ0MJueSiGd7MezOj9x6dxhQBoY81WdWkbj9tVtvxsA27FSWUF4gIKk7QOW1bURFWs9MX-Rm6nKYNIYQ2Nat7fo7-ru1eRePjgIeQtAp4hLyER7C-wPAZX8fxuWMp4d87Ffx8wPOY024YsY8x7dXs94CnOasZBg8Thj_bkDLYUsY3qXB_LE-F17EgM-RYGCku43b6A3rnVJjg8jleoJ_frh-ubqq7---3V-u7yjDWiKo1DXcN4x0B27Sd7gTXlLcGuLZcQyM416YBWtKeM9cLRkoL6VRvNDPOsgt0e9S1SW3kNvtHlQ8yKS-fgJQHqfLsTQDZOd7buu2d1g0XnesoUVYwB5aCLQsULX7UMjlNUwb3X68mcvFFlglPvsjFF3n0pdC-HmlQ7tx7yHIyHqIpn53BzGUR_5bAl1cCJvjojQq_4PA2_R-ZN7Cd
Cites_doi 10.1371/journal.pone.0267143
10.1201/9781003580782-3
10.3389/fphar.2019.01227
10.1186/s13012-017-0605-9
10.1248/yakushi.20-00196-1
10.1186/s13020-018-0188-7
10.12688/wellcomeopenres.15236.1
10.1016/j.jsps.2023.02.013
10.1016/j.jtcme.2021.07.005
10.1038/s41598-017-07538-5
ContentType Journal Article
Copyright 2024 The Author(s)
Copyright_xml – notice: 2024 The Author(s)
DBID 6I.
AAFTH
AAYXX
CITATION
DOA
DOI 10.1016/j.phyplu.2024.100727
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList


Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2667-0313
ExternalDocumentID oai_doaj_org_article_8f49d169fbb5478f820ad73fed2ed80e
10_1016_j_phyplu_2024_100727
S266703132400201X
GroupedDBID .1-
.FO
0R~
AAEDW
AAHBH
AALRI
AAXUO
AAYWO
ACVFH
ADCNI
ADVLN
AEUPX
AFJKZ
AFPUW
AFRHN
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
EBS
FDB
GROUPED_DOAJ
M~E
OK1
ROL
Z5R
6I.
AAFTH
AAYXX
CITATION
ID FETCH-LOGICAL-c3357-6c54f53480ed568b874b246ce4bd4be5744bc5e2be5943f973087408a9cb3cfd3
IEDL.DBID DOA
ISSN 2667-0313
IngestDate Wed Aug 27 01:31:55 EDT 2025
Tue Jul 01 01:53:42 EDT 2025
Sat Feb 15 15:52:11 EST 2025
Tue Aug 26 17:26:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HACCP
Herb market
HKCSCMM
DH
Herb quality problem
GMP
JADER
HKCMMS
Supply chain
Chinese medicine pharmacist registration
SOP
GAP
HKPC
CMRO
Centralized purchase system
WHO
Language English
License This is an open access article under the CC BY-NC-ND license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3357-6c54f53480ed568b874b246ce4bd4be5744bc5e2be5943f973087408a9cb3cfd3
OpenAccessLink https://doaj.org/article/8f49d169fbb5478f820ad73fed2ed80e
ParticipantIDs doaj_primary_oai_doaj_org_article_8f49d169fbb5478f820ad73fed2ed80e
crossref_primary_10_1016_j_phyplu_2024_100727
elsevier_sciencedirect_doi_10_1016_j_phyplu_2024_100727
elsevier_clinicalkey_doi_10_1016_j_phyplu_2024_100727
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2025
2025-02-00
2025-02-01
PublicationDateYYYYMMDD 2025-02-01
PublicationDate_xml – month: 02
  year: 2025
  text: February 2025
PublicationDecade 2020
PublicationTitle Phytomedicine Plus : International journal of phytotherapy and phytopharmacology
PublicationYear 2025
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Au, C.T., Chow, Y.L., 2022. The feasibility of implementation of the accreditation and registration for the professionals of Chinese medicine pharmacists in Hong Kong (Research Report).
Lo, Yik, Shaw (bib0013) 2018; 13
Wong, Lam, Bian (bib0020) 2017; 7
Ngai, Yang, Chu (bib0014) 2022; 17
Hong Kong Productivity Council, 2014. Guidelines for quality management procedures in traditional Chinese medicine business operations.
Atkins, Francis, Islam (bib0001) 2017; 12
Office Of The Ombudsman of Hong Kong, 2018. Government's proactive investigation report on the regulation of unregistered Chinese patent medicine products.
Yu, Song, Lei (bib0023) 2023; 31
Yik, Wong, Wong (bib0022) 2021; 11
Chinese Medicine Regulatory Office, Department of Health, 2024a. Import and export control of Chinese medicines.
Zhang, Cao, Zhang (bib0024) 2021
Chinese Medicine Regulatory Office, Department of Health, 2024b. Chinese medicines recall.
Pisani, Nistor, Hasnida (bib0016) 2019; 4
Bastille Post. 16 January 2019. The Department of Health was suspected of ineffective control, and the first inspection of Chinese herbal medicines exceeded the standard, and no announcement on the reduced toxicity after the decoction was prepared.
Ichim (bib0011) 2019; 10
Chinese Medicine Regulatory Office, Department of Health, 2021. Revised Hong Kong standards for maximum residue limits of harmful substances in chinese medicinal materials and related implementation plans.
Accessed 17 Feb 2024.
Leung, Cheng (bib0012) 2021; 8
The Audit Commission, 2009. Chapter 4 - control of chinese medicines. In report No 53 of the director of audit.
Chinese Medicine Division of the Department of Health, 2024. Hong Kong Chinese materia medica standards.
Department of Justice, 2024. Cap. 362 trade descriptions ordinance.
Hong Kong Productivity Council, 2024. Hong Kong certification scheme for chinese materia medica and decoction pieces.
Awuchi (bib0003) 2023; 9
Accessed 17 February 2024.
Sakai (bib0017) 2021; 141
(bib0021) 2017
Sakai (10.1016/j.phyplu.2024.100727_bib0017) 2021; 141
Wong (10.1016/j.phyplu.2024.100727_bib0020) 2017; 7
Awuchi (10.1016/j.phyplu.2024.100727_bib0003) 2023; 9
Yu (10.1016/j.phyplu.2024.100727_bib0023) 2023; 31
Ichim (10.1016/j.phyplu.2024.100727_bib0011) 2019; 10
Yik (10.1016/j.phyplu.2024.100727_bib0022) 2021; 11
Atkins (10.1016/j.phyplu.2024.100727_bib0001) 2017; 12
Lo (10.1016/j.phyplu.2024.100727_bib0013) 2018; 13
10.1016/j.phyplu.2024.100727_bib0010
Pisani (10.1016/j.phyplu.2024.100727_bib0016) 2019; 4
(10.1016/j.phyplu.2024.100727_bib0021) 2017
10.1016/j.phyplu.2024.100727_bib0004
10.1016/j.phyplu.2024.100727_bib0015
10.1016/j.phyplu.2024.100727_bib0002
10.1016/j.phyplu.2024.100727_bib0007
10.1016/j.phyplu.2024.100727_bib0008
10.1016/j.phyplu.2024.100727_bib0019
10.1016/j.phyplu.2024.100727_bib0005
10.1016/j.phyplu.2024.100727_bib0006
10.1016/j.phyplu.2024.100727_bib25
Ngai (10.1016/j.phyplu.2024.100727_bib0014) 2022; 17
10.1016/j.phyplu.2024.100727_bib0009
Leung (10.1016/j.phyplu.2024.100727_bib0012) 2021; 8
Zhang (10.1016/j.phyplu.2024.100727_bib0024) 2021
References_xml – reference: Hong Kong Productivity Council, 2014. Guidelines for quality management procedures in traditional Chinese medicine business operations.
– volume: 13
  start-page: 1
  year: 2018
  end-page: 8
  ident: bib0013
  article-title: Effective authentication of placenta hominis
  publication-title: Chin. Med.
– volume: 4
  start-page: 70
  year: 2019
  ident: bib0016
  article-title: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
  publication-title: Wellcome Open. Res.
– volume: 141
  start-page: 165
  year: 2021
  end-page: 168
  ident: bib0017
  article-title: Role and applicability of spontaneous reporting databases in medical big data (医療ビッグデータにおける自発報告データベースの位置づけと利用可能性)
  publication-title: Yakugaku Zasshi
– volume: 12
  start-page: 1
  year: 2017
  end-page: 18
  ident: bib0001
  article-title: A guide to using the theoretical domains framework of behaviour change to investigate implementation problems
  publication-title: Implement. Sci.
– reference: Chinese Medicine Regulatory Office, Department of Health, 2021. Revised Hong Kong standards for maximum residue limits of harmful substances in chinese medicinal materials and related implementation plans.
– reference: Department of Justice, 2024. Cap. 362 trade descriptions ordinance.
– reference: Chinese Medicine Division of the Department of Health, 2024. Hong Kong Chinese materia medica standards.
– year: 2017
  ident: bib0021
  article-title: WHO global surveillance and monitoring system for substandard and falsified medical products
– volume: 31
  start-page: 597
  year: 2023
  end-page: 604
  ident: bib0023
  article-title: Anti-fatigue effect of traditional Chinese medicines: a review
  publication-title: Saudi Pharm. J.
– volume: 11
  start-page: 598
  year: 2021
  end-page: 600
  ident: bib0022
  article-title: HerBChain, a blockchain-based informative platform for quality assurance and quality control of herbal products
  publication-title: J. Tradit. Complement. Med.
– reference: Chinese Medicine Regulatory Office, Department of Health, 2024a. Import and export control of Chinese medicines.
– reference: . Accessed 17 February 2024.
– volume: 10
  start-page: 1227
  year: 2019
  ident: bib0011
  article-title: The DNA-based authentication of commercial herbal products reveals their globally widespread adulteration
  publication-title: Front. Pharmacol.
– volume: 8
  start-page: 1
  year: 2021
  end-page: 6
  ident: bib0012
  article-title: Quality control of medicinal herbs—has good agricultural practice (GAP) helped?
  publication-title: Open Access Library Journal
– reference: Hong Kong Productivity Council, 2024. Hong Kong certification scheme for chinese materia medica and decoction pieces.
– volume: 17
  year: 2022
  ident: bib0014
  article-title: Multi-methodological approach for the quality assessment of senecionis scandentis herba (Qianliguang) in the herbal market
  publication-title: PLoS. One
– start-page: 1
  year: 2021
  end-page: 7
  ident: bib0024
  article-title: Construction status and development strategy of GAP bases for chinese herbal medicine
  publication-title: China J. Chin. Materia Medica
– volume: 9
  year: 2023
  ident: bib0003
  article-title: HACCP, quality, and food safety management in food and agricultural systems
  publication-title: Cogent. Food Agric.
– reference: Bastille Post. 16 January 2019. The Department of Health was suspected of ineffective control, and the first inspection of Chinese herbal medicines exceeded the standard, and no announcement on the reduced toxicity after the decoction was prepared.
– reference: Chinese Medicine Regulatory Office, Department of Health, 2024b. Chinese medicines recall.
– reference: . Accessed 17 Feb 2024.
– volume: 7
  start-page: 7513
  year: 2017
  ident: bib0020
  article-title: Morbidity pattern of traditional Chinese medicine primary care in the Hong Kong population
  publication-title: Sci Rep.
– reference: The Audit Commission, 2009. Chapter 4 - control of chinese medicines. In report No 53 of the director of audit.
– reference: Au, C.T., Chow, Y.L., 2022. The feasibility of implementation of the accreditation and registration for the professionals of Chinese medicine pharmacists in Hong Kong (Research Report).
– reference: Office Of The Ombudsman of Hong Kong, 2018. Government's proactive investigation report on the regulation of unregistered Chinese patent medicine products.
– ident: 10.1016/j.phyplu.2024.100727_bib0002
– volume: 9
  issue: 1
  year: 2023
  ident: 10.1016/j.phyplu.2024.100727_bib0003
  article-title: HACCP, quality, and food safety management in food and agricultural systems
  publication-title: Cogent. Food Agric.
– ident: 10.1016/j.phyplu.2024.100727_bib0005
– volume: 17
  issue: 4
  year: 2022
  ident: 10.1016/j.phyplu.2024.100727_bib0014
  article-title: Multi-methodological approach for the quality assessment of senecionis scandentis herba (Qianliguang) in the herbal market
  publication-title: PLoS. One
  doi: 10.1371/journal.pone.0267143
– ident: 10.1016/j.phyplu.2024.100727_bib0006
– ident: 10.1016/j.phyplu.2024.100727_bib0004
  doi: 10.1201/9781003580782-3
– volume: 8
  start-page: 1
  issue: 12
  year: 2021
  ident: 10.1016/j.phyplu.2024.100727_bib0012
  article-title: Quality control of medicinal herbs—has good agricultural practice (GAP) helped?
  publication-title: Open Access Library Journal
– volume: 10
  start-page: 1227
  year: 2019
  ident: 10.1016/j.phyplu.2024.100727_bib0011
  article-title: The DNA-based authentication of commercial herbal products reveals their globally widespread adulteration
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2019.01227
– volume: 12
  start-page: 1
  issue: 1
  year: 2017
  ident: 10.1016/j.phyplu.2024.100727_bib0001
  article-title: A guide to using the theoretical domains framework of behaviour change to investigate implementation problems
  publication-title: Implement. Sci.
  doi: 10.1186/s13012-017-0605-9
– volume: 141
  start-page: 165
  issue: 2
  year: 2021
  ident: 10.1016/j.phyplu.2024.100727_bib0017
  article-title: Role and applicability of spontaneous reporting databases in medical big data (医療ビッグデータにおける自発報告データベースの位置づけと利用可能性)
  publication-title: Yakugaku Zasshi
  doi: 10.1248/yakushi.20-00196-1
– ident: 10.1016/j.phyplu.2024.100727_bib0009
– ident: 10.1016/j.phyplu.2024.100727_bib0010
– volume: 13
  start-page: 1
  issue: 1
  year: 2018
  ident: 10.1016/j.phyplu.2024.100727_bib0013
  article-title: Effective authentication of placenta hominis
  publication-title: Chin. Med.
  doi: 10.1186/s13020-018-0188-7
– year: 2017
  ident: 10.1016/j.phyplu.2024.100727_bib0021
– ident: 10.1016/j.phyplu.2024.100727_bib0008
– start-page: 1
  year: 2021
  ident: 10.1016/j.phyplu.2024.100727_bib0024
  article-title: Construction status and development strategy of GAP bases for chinese herbal medicine
  publication-title: China J. Chin. Materia Medica
– ident: 10.1016/j.phyplu.2024.100727_bib25
– ident: 10.1016/j.phyplu.2024.100727_bib0007
– ident: 10.1016/j.phyplu.2024.100727_bib0015
– volume: 4
  start-page: 70
  year: 2019
  ident: 10.1016/j.phyplu.2024.100727_bib0016
  article-title: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
  publication-title: Wellcome Open. Res.
  doi: 10.12688/wellcomeopenres.15236.1
– volume: 31
  start-page: 597
  issue: 4
  year: 2023
  ident: 10.1016/j.phyplu.2024.100727_bib0023
  article-title: Anti-fatigue effect of traditional Chinese medicines: a review
  publication-title: Saudi Pharm. J.
  doi: 10.1016/j.jsps.2023.02.013
– ident: 10.1016/j.phyplu.2024.100727_bib0019
– volume: 11
  start-page: 598
  issue: 6
  year: 2021
  ident: 10.1016/j.phyplu.2024.100727_bib0022
  article-title: HerBChain, a blockchain-based informative platform for quality assurance and quality control of herbal products
  publication-title: J. Tradit. Complement. Med.
  doi: 10.1016/j.jtcme.2021.07.005
– volume: 7
  start-page: 7513
  year: 2017
  ident: 10.1016/j.phyplu.2024.100727_bib0020
  article-title: Morbidity pattern of traditional Chinese medicine primary care in the Hong Kong population
  publication-title: Sci Rep.
  doi: 10.1038/s41598-017-07538-5
SSID ssj0002513194
Score 2.2819507
Snippet The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified recurrently to...
Background: The Hong Kong Department of Health has been inspecting numerous medicinal herbs circulating in the market every year. Herbs have been identified...
SourceID doaj
crossref
elsevier
SourceType Open Website
Index Database
Publisher
StartPage 100727
SubjectTerms Centralized purchase system
Chinese medicine pharmacist registration
Herb market
Herb quality problem
Supply chain
Title Advancing global herbal medicine: Enhancing herb quality through innovative strategies explored in Hong Kong - An international hub
URI https://www.clinicalkey.com/#!/content/1-s2.0-S266703132400201X
https://dx.doi.org/10.1016/j.phyplu.2024.100727
https://doaj.org/article/8f49d169fbb5478f820ad73fed2ed80e
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BTtwwELUqTlwqWopYSqs5IE4bkcR24vRG0aIV1SIOrLS3KLbHYhEKCHaR9tJLf7xjO4Hc9sIliWI7sTwjz0wy8x5jJ3lqeNrkmGijKEBRqUyqkpMuV9ph5jLEgM4_uy6mc3G1kIsB1ZfPCYvwwHHhzpQTlc2KymntoaccWazGltyhzdGqFP3uSzZvEEz5PZisNumW6GvlQkIXTfvpYU0hYS5CboAnkhnYogDZPzBJAzNzucc-d_4hnMd5fWGfsP3KTm8iwPRmDLfv9VIvYziFm3fo6c0--xdIkg2ZI4hIH0Dd_an_hf4LJu1d18M3QSyq3EDH1wPLjiX1FeFl1cNIAIZMPbTUDNNHGvvHHxI4b2E5_KQId2v9jc0vJ7cX06SjWUgM57JMCiOFk5zkhFYWSqtS6FwUBoW2QqMshdBGYk6XleCORJl6Hj_VVEZz4yw_YDvtY4uHDExhjdIUrPMiFZiZBi1vCuV0k3GplByxpF_w-imiadR9mtl9HQVUewHVUUAj9ttL5a2vx8ION0hD6k5D6m0aMmKyl2ndl5vSBkkPWm55efk2rnNHopuxdeTRR0z7O9vNPddwyBA_Zjur5zX-IAdopX8GXafj7O_kP-dXCSo
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advancing+global+herbal+medicine%3A+Enhancing+herb+quality+through+innovative+strategies+explored+in+Hong+Kong+-+An+international+hub&rft.jtitle=Phytomedicine+Plus+%3A+International+journal+of+phytotherapy+and+phytopharmacology&rft.au=Ngai%2C+Hiu-Lam&rft.au=Shaw%2C+Pang-Chui&rft.date=2025-02-01&rft.pub=Elsevier+B.V&rft.issn=2667-0313&rft.eissn=2667-0313&rft.volume=5&rft.issue=1&rft_id=info:doi/10.1016%2Fj.phyplu.2024.100727&rft.externalDocID=S266703132400201X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2667-0313&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2667-0313&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2667-0313&client=summon